Clinical Trial Update: Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a single-pill combination of capecitabine and cyclophosphamide in metastatic breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Metastatic

Drugs mentioned

• Capecitabine and Cyclophosphamide combination (single-pill formulation)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer Metastatic | Phase 2 | Status: COMPLETED